“The Efficacy and Toxicity of Programs MOPP, ABVD, BEACOPP-Base in Primary Hodgkin’s Lymphoma Patients With a Poor Prognosis”. Voprosy Onkologii, vol. 59, no. 2, Dec. 2013, pp. 59-65, https://doi.org/10.37469/0507-3758-2013-59-2-59-65.